A new Alzheimer’s drug brings hope, controversy

The FDA’s current approval of a brand-new drug, Aduhelm, to remove the development of amyloid plaques in the brain is possibly good information for the 6 million Americans who deal with Alzheimer’s illness. The approval procedure for Aduhelm has stirred conflict. Contributor Susan Spencer chats with specialists regarding the scientific benefits of this new course of medications; as well as with early-onset Alzheimer’s people, consisting of a former neurologist who signed up in a very early trial of Aduhelm.

” CBS Sunday Morning” functions stories on the arts, music, nature, amusement, sports, history, scientific research as well as Americana, and also highlights distinct human achievements as well as achievements. Check neighborhood listings for CBS Sunday Morning program times.

Subscribe to the “CBS Sunday Morning” YouTube network: http://bit.ly/20gXwJT
Obtain even more of “CBS Sunday Morning”: http://cbsn.ws/1PlMmAz
Follow “CBS Sunday Morning” on Instagram: http://bit.ly/23XunIh
Like “CBS Sunday Morning” on Facebook: https://bit.ly/3sRgLPG
Adhere To “CBS Sunday Morning” on Twitter: http://bit.ly/1RquoQb
Sign up for our e-newsletter: http://cbsn.ws/1RqHw7T
Download the CBS News application: http://cbsn.ws/1Xb1WC8
Try Paramount+ free: https://bit.ly/2OiW1kZ

For video clip licensing questions, get in touch with: [email protected]